Drugs: Cost Effectiveness
(asked on 19th October 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what budget NHS England has allocated for discretionary investment in new drugs and treatments not considered by NICE in 2018-19.
This question was answered on 29th October 2018
A process of relative prioritisation for determining discretionary investment in new specialised services was first introduced in 2016/17. Investment decisions are informed following advice from NHS England’s independently chaired Clinical Priorities Advisory Group and against a budget that is fixed annually. In 2018/19, £25 million was set aside for this purpose.